Business

April 24, 2014

Quintiles signs major deal with Biogen Idec

Quintiles has inked a partnership with biotechnology company Biogen Idec that one analyst estimates could eventually mean more than $100 million in revenue for the Durham-based pharmaceutical services giant.

Related content

Comments

Videos

Editor's Choice Videos